Opioid Use in Pregnancy and Neonatal Opioid Withdrawal

Last modified by Doug Maynard on 2018/04/12 22:00

This talk will discuss the pharmacology of opioids including why people respond to opioids differently. The main focus of this session will be on the use of opioids during pregnancy and the potential effects on the newborn, including the development of neonatal abstinence syndrome or neonatal opioid withdrawal. Recent research, ongoing and future research studies in neonatal abstinence syndrome will be presented for discussion.


Click here to download the slides from this presentation.

CHI headshot.JPGLauren E Kelly Ph.D., M.Sc., C.C.R.P.

Dr. Lauren E Kelly has a PhD in Pharmacology and completed two post-doctoral fellowships at the Hospital for Sick Children and Mount Sinai Hospital in Toronto. Dr. Kelly is a systematic reviewer with the Cochrane Neonatal Review Group and a Certified Clinical Research Professional. She was recruited to the University of Manitoba in September 2017 and is an Assistant Professor in the Departments of Pediatrics & Child Health and Community Health Sciences. Dr. Kelly has been working in pediatric clinical research since 2008 and her research focuses on pediatric and neonatal opioid response.

Created by Doug Maynard on 2018/03/13 20:03